SAN FRANCISCO, March 30, 2017 /PRNewswire/ --
The global antibody production market is expected to reacha value of USD 22.6 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for therapeutic antibodies including monoclonal and polyclonal antibodies is a major factor that drives growth
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Patent expiry of several blockbuster monoclonal antibodies in the near future, is another major factor supporting the growth of the antibody production market. Several antibodies such as Avastin, Herceptin, and Mabthera are going to lose their patents in a few years. For instance, the patent of Herceptin (trastuzumab) expired in Europe in July 2014 and will expire in the U.S. in June 2019. Many companies such as Amgen Inc., Synthon, Biocon, and Pfizer Inc. are developing biosimilar for trastuzumab, which is expected to propel the demand for antibody production products.
Browse full research report with TOC on "Antibody Production Market By Type (Polyclonal Antibody, Monoclonal Antibody), By Process (Upstream Processing, Downstream Processing, Filtration), By End-Use, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/antibody-production-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the antibody production market on the basis of type, process, end-use, and region:
Read Our Blog: Antibody Production Market Outlook: Analyst Perspective
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Malaria is a dangerous disease with lethal consequences that requires protective measures for ...
Merkel cell carcinoma is a rare and a highly aggressive primary skin cancer that grows rapidly and ...
Vitrectomy is a surgical procedure performed to remove a part or whole of the vitreous humor ...View All